ocular drug delivery Flashcards
what are the different layers of the eyes
outer - sclera and cornea
middle- iris, ciliary body and choroid
inner - retina
chambers - anterior and posterior, vitreous cavity
what are the barriers to topical ocular ddel
pre-corneal factors
- solution drainage, blinking, tear film, tear turnover
- induced lacrimation
- mucin in tear film is hydrophobic
anatomical
- layers of cornea, conjunctiva and sclera
what are the barriers to systemic ocular ddel
blood aqueous barrier
blood retinal barrier
why is the blood retinal barrier a barrier to systemic ocular ddel
requires specific targeting systems, limited access requires high oral doses
what considerations need to be made when developing drugs for ocular delivery
osmolarity
pH
surface tension
viscosity
why does osmolarity need to be considered when developing drugs for ocular delivery
determined by concentration of lacrimal fluids - 0.9-1%
hypotonic cause oedema, hypertonic dry the corneal epithelium
why does pH need to be considered when developing drugs for ocular delivery
important in controlling ionisation and corneal permeability (6.9-7.5)
why does surface tension need to be considered when developing drugs for ocular delivery
drops that lower the surface tension of the eye
- destabilise tear film
- disperse lipids into droplets
- solubilised by drug/surfactants in formulation
why does viscosity need to be considered when developing drugs for ocular delivery
to prolong retention in tear film
PVP, PVA, MC, HPMC
blinking force limits viscosity
what are the advantages and disadvantages of using solutions for topical ocular ddel
easy and cheap
rapid onset of action with good dose uniformity
rapidly drained from the eye - proportional to drop size
variations in amount dispensed
why are suspensions used for ocular ddel
administration of soluble aqueous drugs - steroids and to prolong release
why are gels used in ocular ddel
semi-solid with water soluble base - polymers dispersed in liquids
can be activated to undergo phase transition in the eye
what are the 3 routes of systemic/direct ocular ddel
intracameral - anterior chambers
intravitreal
periocular (subconjunctival, retrobulbar and peribulbar)
what are the advantages and disadvantages of intravitreal injection for ocular ddel
Distribution in vitreous is non-uniform – LMW can rapidly distribute, HMW cannot
Best way to deliver but poor compliance
Drug retention requires frequent administration
what are punctual plugs
plugs inserted into tear ducts that release drugs over 1-2m